Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-01-29

Clinical Trial Update: Topical Use of Corticosteroid to Prevent Epiretinal Membrane Following Retinal Tear [NA]

View source ↗

Summary

The trial update reports completion of a study evaluating topical corticosteroids to prevent epiretinal membrane formation after retinal tears.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical corticosteroid (corticosteroid)

Snippet

Sponsor: Unity Health Toronto | Conditions: Epiretinal Membrane | NA | Status: COMPLETED